News About: Pharm. Industry
Domestic pharmaceutical firms keen to enter into antidiabetic market
As the patent of Handok-Aventis Pharma's Amaryl (glimepiride) is already expired and its post-surveillance system will be completed in July of next year, a number of domestic firms are on the lookout for potential rev...
Korea's drug exporters faces more regulatory restriction in Eastern Europe
As 10 Eastern Europe countries will likely be affiliated with the European Union in May of next year, Korea's drug exporters are bracing for proper measures to cope with more complicated regulatory procedures and test...
Korean males with electile dysfunction still overdependent on traditional therapies
Seven out of ten Korean males with electile dysfunction remain highly dependent upon unreliable traditional therapies and stamina foods prior to their hospital visits, while they are eager to discuss the sexual proble...
Anti-impotence drug market to be contested by three multinational firms
Business sources say that the domestic market for oral anti-impotence drugs is soon likely to emerge as an arena of tripartite competition among foreign-invested pharmaceutical firms.
More recently, the Korea Food ...
Pharmaceutical companies gearing up sports marketingSome domestic pharmaceutical firms are willing to adopt sports marketing-related strategies including marathon events which have been led by company's sports-lover groups, as pa...
|
AstraZeneca Korea president resigns
Lee Yang-bok, president of AstraZeneca Korea, resigned the post on June 18 and Philipe Meyer, marketing director at an Asia-Pacific region, will assume the presidency for the time being, the Korean subsidiary said rec...
Share of ethical products expanding greatly in the wake of implementation of SDP function
Since the implementation of a new system of separating drug dispensing from medical practice, the output gap in the share of both ethical drugs and OTCs in domestic pharmaceutical market has been expanding, ...
Brisk M&A in domestic pharmaceutical industry
Stimulated by the current consensus that domestic pharmaceutical industry is one of the high value-added industries and growing concern on the biotechnology field, the M&A fever are pronouncing among pharmaceuticals f...
Domestic 7-ACA makers bracing for lower export price
Korea's pharmaceutical makers producing 7-ACA (7-aminocephalosporanic acid), an intermediate of cephalosporin antibiotic, are now striving to cope with its lower pricing of $98.0 kg offered by Chinese counterparts thi...
Internet drug purchase and payment program developed.
Aya dot com (President: Hwang Kang-choon), an internet venture company, has developed a P2P solution program for an internet drug business between drug companies and pharmacy customers financially supported by the Kor...
